ADAM10 and colorectal cancer: Similarly, miR-365 expression is low, whereas ADAM10 expression is upregulated in triple-negative breast cancer cells compared to normal breast cancer cells, and ADAM10 has been identified as a direct target of miR-365 in these [76] as well as in colorectal cancer and hepatocellular carcinoma cells [59,78].